VIVS Stock Analysis: Buy, Sell, or Hold?
VIVS - VivoSim Labs, Inc. Common Stock
$2.92
1.22 (71.76%)
▲
SELL
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 18, 2026
17d
Get Alerted When VIVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
14 traders called VIVS this week
94% bullish • 1 bearish
94% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⚠️ CAUTION: VIVS is extended with warning signals. Consider taking profits or waiting for better entry.
⚠️ CAUTION: VIVS is extended with warning signals. Consider taking profits or waiting for better entry.
In-depth Analysis How we analyze
Valuation Analysis: VIVS is currently trading at $2.92, which is considered extended relative to its 30-day fair value range of $1.76 to $2.20.
Technical Outlook: Technically, VIVS is in a strong downtrend. The price is approaching resistance at $2.96. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 71.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Given the valuation headwinds and technical position, caution is warranted at these levels.
Technical Outlook: Technically, VIVS is in a strong downtrend. The price is approaching resistance at $2.96. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 71.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Given the valuation headwinds and technical position, caution is warranted at these levels.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.76 -
$2.20
Company Quality Score
58/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
33.5%
Protect Your Profits
Before you sell your VIVS shares, consider hedging with options to lock in your gains without triggering a tax event.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+32.7% above fair value)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Strong upward momentum (+71.8%)
Fair Price Analysis
30-Day Fair Range
$1.76 -
$2.20
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.70
Resistance Level
$2.96
Current Trend
Strong Downtrend
Fundamental Context
Revenue Growth (YoY)
75.9%
Last updated: January 31, 2026 11:44 AM ET
Data refreshes hourly during market hours. Next update: 12:44 PM
Data refreshes hourly during market hours. Next update: 12:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VIVS showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced VIVS Option Strategies
Professional options setups generated by AI based on today's VIVS price and gamma walls.
